Nearly a Quarter of U.S. Adults Received Mental Health Treatment in 2023: A Closer Look at the SAMHSA Report
In 2023, nearly a quarter of the adult population in the United States sought mental health treatment, according to the Substance Abuse and Mental...
FDA Rejects MDMA-Assisted Therapy for PTSD: What’s Next for Psychedelic Medicine?
After years of groundbreaking clinical trials and high expectations from both the medical and psychedelic research communities, Lykos Therapeutics has received a disappointing response...
America’s Behavioral Health Workforce Crisis: A Look at the Challenges and Solutions in Psychiatry
America is facing an increasingly dire behavioral health workforce crisis. Despite the rising demand for mental health services, the system is struggling to meet...
Bridging the Gap in Medicare Coverage for Substance Use Disorder Treatment: A Closer Look at the Residential Recovery for Seniors Act
For years, one of the most overlooked groups in the substance use disorder (SUD) treatment conversation has been older adults. Despite the growing recognition...
Private Equity in Behavioral Health: Shifting Dynamics and Opportunities for 2024 and Beyond
As we enter the second half of 2024, there’s growing optimism in the private equity (PE) community regarding the future of healthcare investments. While...
The Autism CARES Act of 2024: A Landmark Step Forward for Autism Research and Services
In an unprecedented move for the autism community, U.S. legislators are advancing the Autism Collaboration, Accountability, Research, Education, and Support (CARES) Act of 2024—the...
